Literature DB >> 22465787

Histological classification of malignant renal tumours at a time of major diagnostic and therapeutic changes.

E Compérat1, P Camparo.   

Abstract

Renal cancers account for approximately 3% of adult cancers and the mean age of diagnosis is 65, with men affected two to three times more frequently than women. However, an increase is being seen in kidney tumours also in young adults and in women. The classification of renal tumours includes both benign and malignant tumours, and is currently quite exhaustive, but may be even more extensive in the coming years, particularly for tumours in renal impairment. Except for certain specific entities (such as chromophobe carcinoma), two criteria are required to correctly classify malignant kidney tumours: the Fuhrman grade, and the pTNM stage, defining tumour extension. The stage and grade are applicable in the same way, regardless of the nature of the tumours; for a given group, they are the best prognostic factors.
Copyright © 2012 Éditions françaises de radiologie. Published by Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22465787     DOI: 10.1016/j.diii.2012.01.015

Source DB:  PubMed          Journal:  Diagn Interv Imaging        ISSN: 2211-5684            Impact factor:   4.026


  15 in total

1.  TR4 nuclear receptor promotes clear cell renal cell carcinoma (ccRCC) vasculogenic mimicry (VM) formation and metastasis via altering the miR490-3p/vimentin signals.

Authors:  Jian Bai; Shuyuan Yeh; Xiaofu Qiu; Linyi Hu; Jun Zeng; Yangke Cai; Li Zuo; Gonghui Li; Guosheng Yang; Chawnshang Chang
Journal:  Oncogene       Date:  2018-07-04       Impact factor: 9.867

2.  Preclinical studies using miR-32-5p to suppress clear cell renal cell carcinoma metastasis via altering the miR-32-5p/TR4/HGF/Met signaling.

Authors:  Mingchao Wang; Yin Sun; Junjie Xu; Jieyang Lu; Kefeng Wang; Dong-Rong Yang; Guosheng Yang; Gonghui Li; Chawnshang Chang
Journal:  Int J Cancer       Date:  2018-04-02       Impact factor: 7.396

3.  Long noncoding RNA HOTAIR promotes renal cell carcinoma malignancy through alpha-2, 8-sialyltransferase 4 by sponging microRNA-124.

Authors:  Yue Pan; Yongjin Wu; Jialei Hu; Yujia Shan; Jia Ma; Huipeng Ma; Xia Qi; Li Jia
Journal:  Cell Prolif       Date:  2018-08-13       Impact factor: 6.831

Review 4.  Melatonin for the prevention and treatment of cancer.

Authors:  Ya Li; Sha Li; Yue Zhou; Xiao Meng; Jiao-Jiao Zhang; Dong-Ping Xu; Hua-Bin Li
Journal:  Oncotarget       Date:  2017-06-13

5.  Targeting newly identified ERβ/TGF-β1/SMAD3 signals with the FDA-approved anti-estrogen Faslodex or an ERβ selective antagonist in renal cell carcinoma.

Authors:  Wenbin Song; Dalin He; Yule Chen; Chiuan-Ren Yeh; Iawen Hsu; Qingbo Huang; Xu Zhang; Luke Sien-Shih Chang; Li Zuo; Jiasheng Chen; Karen M Doersch; Chawnshang Chang; Lei Li; Shuyuan Yeh
Journal:  Mol Oncol       Date:  2018-10-30       Impact factor: 6.603

6.  Down-regulation of transient receptor potential melastatin member 7 prevents migration and invasion of renal cell carcinoma cells via inactivation of the Src and Akt pathway.

Authors:  Yun-Sok Ha; Yeon-Yong Kim; Na Hee Yu; So Young Chun; Seock Hwan Choi; Jun Nyung Lee; Bum Soo Kim; Eun Sang Yoo; Tae Gyun Kwon
Journal:  Investig Clin Urol       Date:  2018-05-18

7.  HCRP-1 regulates cell migration and invasion via EGFR-ERK mediated up-regulation of MMP-2 with prognostic significance in human renal cell carcinoma.

Authors:  Feifei Chen; Junpeng Deng; Xin Liu; Wang Li; Junnian Zheng
Journal:  Sci Rep       Date:  2015-08-25       Impact factor: 4.379

8.  Assessment of Semiquantitative Parameters of Dynamic Contrast-Enhanced Perfusion MR Imaging in Differentiation of Subtypes of Renal Cell Carcinoma.

Authors:  Ahmed Abdel Khalek Abdel Razek; Amani Mousa; Ahmed Farouk; Nancy Nabil
Journal:  Pol J Radiol       Date:  2016-03-06

9.  Tetrandrine inhibits migration and invasion of human renal cell carcinoma by regulating Akt/NF-κB/MMP-9 signaling.

Authors:  Shurui Chen; Wei Liu; Ke Wang; Yizeng Fan; Jiaqi Chen; Jianbin Ma; Xinyang Wang; Dalin He; Jin Zeng; Lei Li
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

10.  Rhein inhibits malignant phenotypes of human renal cell carcinoma by impacting on MAPK/NF-κB signaling pathways.

Authors:  Ya-Li Ma; Fang Chen; Jun Shi
Journal:  Onco Targets Ther       Date:  2018-03-14       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.